| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517973 Expression vector comprising nucleotide sequences coding astrocyte enhanced/suppressed gene sequences for use as tool in identifying modulators for treatment and prevention of viral-related nervous system disorders |
| 04/14/2009 | US7517972 Nucleic acid sequences encoding a bitter taste receptor, T2R76 |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517966 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for medical diagnosis, prevention of viral and microbial infections, and as antitumor agents |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517956 insecticidal proteins isolated from gramnegative bacteria, used for controlling insects |
| 04/14/2009 | US7517954 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 04/14/2009 | US7517948 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517687 Sulfur-oxidizing plant growth promoting rhizobacteria for enhanced canola performance |
| 04/14/2009 | US7517686 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/14/2009 | US7517685 of tolyplocladium comprising a nucleotide sequence capable of controlling expression of a gene when in a fungal species and coding for proteins having hydrolase enzyme activity, antibodies, growth factors, growth inhibitors and tissue activators |
| 04/14/2009 | US7517684 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 04/14/2009 | US7517683 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 04/14/2009 | US7517676 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517670 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2009 | US7517663 Rabbit monoclonal antibody against Id1 protein |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517647 Screening retroviral cDNA library to identify transforming growth factor activator for use tool in prevention and treatment of cell proliferative and inflammatory disorders |
| 04/14/2009 | US7517533 Pseudomonas aeruginosa antigens |
| 04/14/2009 | US7517521 Transplanting and propagating neuronal stem cells for use as tools in prevention and treatment of nervous system disorders |
| 04/14/2009 | CA2321215C Hybrid adenovirus-aav virus and method of use thereof |
| 04/14/2009 | CA2318576C Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 04/14/2009 | CA2307175C Modified vitamin k-dependent polypeptides |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2225852C Anti-fas ligand antibody and assay method using the anti-fas ligand antibody |
| 04/14/2009 | CA2208237C Nuclear protein serine/threonine kinases |
| 04/14/2009 | CA2201887C Patched genes and their use |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/09/2009 | WO2009046412A1 Systems and methods for evaluating operating conditions in a bioreactor using gene expression and abundance tracking |
| 04/09/2009 | WO2009046335A1 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/09/2009 | WO2009046334A1 Mutated acetohydroxyacid synthase genes in brassica |
| 04/09/2009 | WO2009046123A2 Nlrr-1 antagonists and uses thereof |
| 04/09/2009 | WO2009045819A2 Symbiotic biological systems as platforms for sensing, production, and intervention |
| 04/09/2009 | WO2009045506A2 Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 04/09/2009 | WO2009045370A2 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| 04/09/2009 | WO2009045360A2 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| 04/09/2009 | WO2009045359A1 Skin replacement compositions and methods |
| 04/09/2009 | WO2009045308A2 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 04/09/2009 | WO2009045201A1 Cancer stem cells |
| 04/09/2009 | WO2009045179A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 04/09/2009 | WO2009044943A1 Various human dental stem cells having a mineralization ability and the method for culturing them |
| 04/09/2009 | WO2009044561A1 ANTI-proNT/NMN MONOCLONAL ANTIBODY |
| 04/09/2009 | WO2009044553A1 Method for screening of therapeutic agent for anemia |
| 04/09/2009 | WO2009044379A2 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord |
| 04/09/2009 | WO2009043931A1 Non-conventional nkt cells for use in cancer therapy |
| 04/09/2009 | WO2009043159A1 Neural tumor stem cells and methods of use thereof |
| 04/09/2009 | WO2009023271A3 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 04/09/2009 | WO2009016078A3 Method for culturing mammalian stem cells |
| 04/09/2009 | WO2009010661A3 Reactor for the implementation of a bone tissue culture method |
| 04/09/2009 | WO2009009591A4 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 04/09/2009 | WO2008109883A3 Micromechanical devices for control of cell-cell interaction, and methods of use thereof |
| 04/09/2009 | WO2008079298A3 Cells for detection and production of influenza and parainfluenza viruses |
| 04/09/2009 | WO2008063760A3 Methods for treating cancer targeting transglutaminase |
| 04/09/2009 | WO2008049098A3 ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR α1 |
| 04/09/2009 | WO2008019062A3 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/09/2009 | WO2007134014A3 Compounds and methods for modulating expression of gcgr |
| 04/09/2009 | WO2007115123A3 Mineralized three-dimensional bone constructs |
| 04/09/2009 | WO2007107996A3 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 04/09/2009 | WO2007099534A3 Compostions and populations of cells obtained from the umbilical cord and methods of producing the same |
| 04/09/2009 | WO2007092196A3 Compositions and methods for treating myeloid proliferative disorders |
| 04/09/2009 | WO2007035363A3 Compositions and methods for the augmentation and repair of defects in tissue |
| 04/09/2009 | WO2006105277A3 Eg1117 and eg307 polynucleotides and uses thereof |
| 04/09/2009 | WO2006098952A3 Corn event 3272 and methods of detection thereof |
| 04/09/2009 | WO2006073446A3 Peptide-mediated protein transduction into cells the hematopoietic lineage |
| 04/09/2009 | WO2006068809A3 Substrate recognition by differentiable human mesenchymal stem cells |
| 04/09/2009 | WO2006049812A3 Process for treating a biological organism |
| 04/09/2009 | WO2006047299A3 Organotypic slice cultures and uses thereof |
| 04/09/2009 | WO2006044333A3 Methods and materials for the inhibition of transplant rejection |
| 04/09/2009 | WO2006036878A3 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 04/09/2009 | WO2006036741A3 Compositions and methods for modulating lignin of a plant |
| 04/09/2009 | WO2006029262A3 Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment |
| 04/09/2009 | WO2006026473A3 METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS |
| 04/09/2009 | WO2006026275A3 Methods for inducing uterine contraction and compositions useful therefor |
| 04/09/2009 | WO2006020240A3 Methods and compositions for bioengineering a tooth |
| 04/09/2009 | WO2006014422A3 Polynucleotide encoding a trim-cyp polypeptide, compositions thereof, and methods of using same |
| 04/09/2009 | WO2005117918A3 Fibrous minerals, methods for their production using a solution-precursor-solid mechanism, and methods of use |
| 04/09/2009 | WO2005026320A3 Entrapped stem cells and uses thereof |
| 04/09/2009 | WO2005017117A3 Multipotent amniotic fetal stem cells (mafsc) and banking of same |
| 04/09/2009 | WO2005007090A3 Inhibitors of the map kinase pathway |
| 04/09/2009 | WO2004101807A3 High troughput monitoring chamber for testing drug effects on repolarization and conduction |
| 04/09/2009 | WO2004084811A3 Crystals and structures of epidermal growth factor receptor kinase domain |
| 04/09/2009 | US20090094717 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 04/09/2009 | US20090094715 Methods of use of antibodies with reduced immunogenicity or toxicity |
| 04/09/2009 | US20090094714 Novel insecticidal polypeptides of given amino acid sequence obtained by culturing Bacillus thuringiensis; for controlling an insect population, such as Colorado potato beetle, southern corn rootworm and western corn rootworm |
| 04/09/2009 | US20090094713 Plant Regulatory Region that Directs Transgene Expression in the Maternal and Supporting Tissue of Maize Ovules and Pollinated Kernels |
| 04/09/2009 | US20090094709 Use of protein phosphatase 2Ce (PP2Ce) having dephosphorylating action on AMPK |
| 04/09/2009 | US20090094708 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives |
| 04/09/2009 | US20090094703 Novel medulloblastoma-forming cell line |
| 04/09/2009 | US20090093622 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 04/09/2009 | US20090093619 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 04/09/2009 | US20090093483 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4 |
| 04/09/2009 | US20090093465 Therapeutic kinase modulators |
| 04/09/2009 | US20090093434 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 04/09/2009 | US20090093416 Caspase inhibitors and uses thereof |
| 04/09/2009 | US20090093409 Neuroprotective synergy of erythropoietin and insulin-like growth factors |
| 04/09/2009 | US20090093407 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |